Line 301: | Line 301: | ||
<hr> | <hr> | ||
<h3>Cloning Signal Peptides with the Signal Peptide-Evaluation Vector</h3> | <h3>Cloning Signal Peptides with the Signal Peptide-Evaluation Vector</h3> | ||
− | <p>Following the evaluation of the multi-template PCR amplification of the SPs, we established a Standard Operating Procedure (SOP) protocol for cloning the SPs using the Signal Peptide-Evaluation Vector (SP-EV). This SOP | + | <p>Following the evaluation of the multi-template PCR amplification of the SPs, we established a Standard Operating Procedure (SOP) protocol for cloning the SPs using the Signal Peptide-Evaluation Vector (SP-EV). This SOP describes the high-throughput approach of screening SPs with a POI. While our project is based in <i>B. subtilis</i> and we use <i>E. coli</i> the cloning host, we believe this SOP can be applied to any organism which is able to perform secretion via the Sec pathway.</p> |
<figure> | <figure> | ||
<figure class="makeresponsive floatleft" style="width:60%; margin-bottom:-20px;"> | <figure class="makeresponsive floatleft" style="width:60%; margin-bottom:-20px;"> | ||
<img class="zoom" src="https://static.igem.org/mediawiki/2017/7/70/SHATTERtheUniverse.gif"><figcaption><b>Figure 4: Animated cloning stages using our EV.</b> The promoter can be exchanged via EcoRI and BsaI (=results in XbaI overhang), to insert Signal Peptides use XbaI and AgeI and use NgoMIV and PstI to exchange of the gene of interest.</figcaption></figure> | <img class="zoom" src="https://static.igem.org/mediawiki/2017/7/70/SHATTERtheUniverse.gif"><figcaption><b>Figure 4: Animated cloning stages using our EV.</b> The promoter can be exchanged via EcoRI and BsaI (=results in XbaI overhang), to insert Signal Peptides use XbaI and AgeI and use NgoMIV and PstI to exchange of the gene of interest.</figcaption></figure> | ||
− | <p>We provide the EV with a xylose inducible promoter (P<sub><i>xylA</i></sub>), which is well characterised for the use in <i>B. subtilis</i>. All the following experiments were performed using this promoter to drive our expression. As a first approach, we wanted to investigate if we could boost the secretion of the native <i>amyE</i> in <i>B. subtilis</i>. We amplified <i>amyE</i> (without its | + | <p>We provide the EV with a xylose inducible promoter (P<sub><i>xylA</i></sub>), which is well characterised for the use in <i>B. subtilis</i>. All the following experiments were performed using this promoter to drive our expression. As a first approach, we wanted to investigate if we could boost the secretion of the native <i>amyE</i> in <i>B. subtilis</i>. We amplified <i>amyE</i> (without its native signal peptide) using the primers iG17P180 and iG17P062, restriction enzymes interfering with the RFC25 standard were removed via mutagenesis PCR using iG17P057 - iG17P062. After sequencing, we stored the biobricked RFC25 compatible <i>amyE</i> version in the pSB1C3 backbone and submitted it to the parts registry (<a target="_blank" href="http://parts.igem.org/Part:BBa_K2273103">BBa_K2273103</a>). We then sub-cloned this part into our EV, via NgoMIV and PstI, replacing the <i>lacZα</i>. Next, we amplified all SPs from each SPM subset using the RFC10 (pre- and suffix) sequences as primers (TM4487 and iG17P039). After the amplification, each subset was digested using XbaI and AgeI. Now, we had everything ready to perform our shotgun ligation approach: we digested the EV (containing the BioBrick <i>amyE</i>) with BsaI and AgeI and ligated equal molar amounts with each SPM subset (a, b, c and d). The ligation mixes were directly <a href="https://2017.igem.org/Team:TU_Dresden/Experiments">transformed into <i>B. subtilis</i></a>. |
</figure> | </figure> | ||
Line 313: | Line 313: | ||
<h3 id="secretion">High throughput screening procedure for <i><b>B. subtilis</b></i></h3> | <h3 id="secretion">High throughput screening procedure for <i><b>B. subtilis</b></i></h3> | ||
<p>After various adjustments to improve the applicability of the Signal Peptide Toolbox, we developed a high throughput screening procedure tailored to fit our model organism <i>B. subtilis</i> and proceeded to identify the most potent SPs for highest secretion of <i>B. subtilis'</i> α-Amylase.</p> | <p>After various adjustments to improve the applicability of the Signal Peptide Toolbox, we developed a high throughput screening procedure tailored to fit our model organism <i>B. subtilis</i> and proceeded to identify the most potent SPs for highest secretion of <i>B. subtilis'</i> α-Amylase.</p> | ||
− | <p>Since we wanted to evaluate amylase secretion efficiency, we performed our transformation into a starch degradation-deficient <i>B. subtilis</i> strain (TMB3547). This strain contains a disruption of the <i>amyE</i> gene, due to the insertion of P<sub><i>veg</i></sub>-<i>lacZ</i>. Fortunately, the strain still contains the necessary flanking regions for | + | <p>Since we wanted to evaluate amylase secretion efficiency, we performed our transformation into a starch degradation-deficient <i>B. subtilis</i> strain (TMB3547). This strain contains a disruption of the <i>amyE</i> gene, due to the insertion of P<sub><i>veg</i></sub>-<i>lacZ</i>. Fortunately, the strain still contains the necessary flanking regions for homologous recombination of the pBS1C vector. Thus, positive integration of the pBS1C-SPM-<i>amyE</i> construct lead to white colonies, when plated on X-Gal containing agar plates. (Figure 5, A)</p> |
− | <p>We obtained colonies from each transformation (SPM a, b, c or d with<i>amyE</i> in the EV) and transferred colonies to: a starch containing screening agar plate (to check for vector integration into the <i>B. subtilis</i> genome) and a second backup agar plate which was spiked with chloramphenicol (to maintain each colony). In our setup, we included a negative control (TMB3547, non starch degrading) and a positive control (W168, native <i>amyE</i> secretion).</p> | + | <p>We obtained colonies from each transformation (SPM a, b, c or d with<i>amyE</i> in the EV) and transferred colonies to: a starch containing screening agar plate (to check for vector integration into the <i>B. subtilis</i> genome) and a second backup agar plate which was spiked with chloramphenicol (to maintain each colony). In our setup, we included a negative control (TMB3547, non starch degrading) and a positive control (W168, native <i>amyE</i> and thereby native amylase secretion).</p> |
<figure> | <figure> | ||
<figure class="makeresponsive floatright" style="width:70%;"> | <figure class="makeresponsive floatright" style="width:70%;"> | ||
<img class="zoom" src="https://static.igem.org/mediawiki/2017/b/ba/PlatesofDOOM.png"><figcaption><b>Figure 5: Handling of <i><b>B. subtilis</b></i> after transformation shown on agar plates.</b> <b>A</b> The transformation agar plate (chloramphenicol and X-Gal). No blue colonies indicate a high transformation efficiency. <b>B</b> The screening agar plate. Zones of degradation indicate successful integration events. The negative control (TMB3547) has been marked with a black box, the positive control (W168 wild type) with a white box respectively. <b>C</b> The backup agar plate containing chloramphenicol. Neither the negative control (black box), nor the positive control (white box).</figcaption></figure> | <img class="zoom" src="https://static.igem.org/mediawiki/2017/b/ba/PlatesofDOOM.png"><figcaption><b>Figure 5: Handling of <i><b>B. subtilis</b></i> after transformation shown on agar plates.</b> <b>A</b> The transformation agar plate (chloramphenicol and X-Gal). No blue colonies indicate a high transformation efficiency. <b>B</b> The screening agar plate. Zones of degradation indicate successful integration events. The negative control (TMB3547) has been marked with a black box, the positive control (W168 wild type) with a white box respectively. <b>C</b> The backup agar plate containing chloramphenicol. Neither the negative control (black box), nor the positive control (white box).</figcaption></figure> | ||
− | <p>To verify positive integration of our EV-SPM-<i>amyE</i> constructs, we poured <a href="https://2017.igem.org/Team:TU_Dresden/Experiments">Lugol’s Iodine solution</a> on the screening plates, which where spiked with starch. Normally, the integration of the EV into the <i>amyE</i> locus of <i>B. subtilis</i>, results in a disruption of the native gene leading to a loss of the enzymatic activity. Therefore, successfully transformed clones would not be able to degrade starch visualisable by no brightened zone of degradation (Figure 5B, black box). But as we performed our transformation into a starch degradation-deficient <i>B. subtilis</i> strain and used | + | <p>To verify positive integration of our EV-SPM-<i>amyE</i> constructs, we poured <a href="https://2017.igem.org/Team:TU_Dresden/Experiments">Lugol’s Iodine solution</a> on the screening plates, which where spiked with starch. Normally, the integration of the EV into the <i>amyE</i> locus of <i>B. subtilis</i>, results in a disruption of the native gene leading to a loss of the enzymatic activity. Therefore, successfully transformed clones would not be able to degrade starch visualisable by no brightened zone of degradation (Figure 5B, black box). But as we performed our transformation into a starch degradation-deficient <i>B. subtilis</i> strain and used amylase as POI, successfully transformed colonies were again able to degrade starch. Thereby, a brightened zone of degradation on the screening agar plate indicated promising colonies (Figure 5, B e.g. top row). The position of successfully transformed colonies was then marked on the backup agar plates (Figure 5, C). Surprisingly, some chloramphenicol resistance clones did not show any zone of starch degradation (compare clone 4 on Figure 5, C and check with the same position on Figure 5, B). We believe that in these cases, only single homologous recombination events occurred.</p> |
− | <p>Having now identified clones with positive integrated EV-SPM-<i>amyE</i> constructs, we proceeded with testing their supernatants in | + | <p>Having now identified clones with positive integrated EV-SPM-<i>amyE</i> constructs, we proceeded with testing their supernatants in an amylase enzyme assay. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/16500607">[8]</a> We therefore, incubated approximately 30 clones of each transformation (with the four different SPM subset) in a 96 well plate using <a href0"https://2017.igem.org/Team:TU_Dresden/Experiments">2xYT medium</a>. We also included the negative control (TMB3547) and the wild type. We inoculated the 96 well plates and incubated the <i>B. subtilis</i> cultures for 8 hours at 37°C with 220 rpm using the plate reader.</p> |
</figure> | </figure> | ||
Line 328: | Line 328: | ||
<figure class="makeresponsive floatright" style="width:60%;"> | <figure class="makeresponsive floatright" style="width:60%;"> | ||
<img class="zoom" src="https://static.igem.org/mediawiki/2017/thumb/3/32/YOURWORLDSHALLSUFFER.png/800px-YOURWORLDSHALLSUFFER.png"><figcaption><b>Figure 7: Sequenced signal peptides in front of <i><b>amyE</b></i>.</b> Fold change in secretion efficiency (amylase activity) over wild type. Depicted candidates were identified by sequencing.</figcaption></figure> | <img class="zoom" src="https://static.igem.org/mediawiki/2017/thumb/3/32/YOURWORLDSHALLSUFFER.png/800px-YOURWORLDSHALLSUFFER.png"><figcaption><b>Figure 7: Sequenced signal peptides in front of <i><b>amyE</b></i>.</b> Fold change in secretion efficiency (amylase activity) over wild type. Depicted candidates were identified by sequencing.</figcaption></figure> | ||
− | <p>After the first 8 hours of incubation, we | + | <p>After the first 8 hours of incubation, we reinoculated the cells in fresh 2xYT medium supplemented with a final concentration of 1% xylose to induce the expression of our constructs driven by P<sub><i>xylA</i></sub>. We incubated the <i>B. subtilis</i> cultures for 16 hours at 37°C with 220 rpm in the plate reader.</p> |
<p>Before separating the supernatant from the cells via centrifuging the 96 well plates, we measured the OD<sub>600</sub> to normalize our data in the end (assuming a direct correlation between bacterial density and secreted protein). Using the harvested supernatants, we applied a microplate reader based starch hydrolysis assay <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/16500607">[8]</a> and normalized the generated data with the OD<sub>600</sub> values to identify the most potent combinations of SPs and <i>B. subtilis’</i> α-Amylase of each SPM subset (Figure 6).</p> | <p>Before separating the supernatant from the cells via centrifuging the 96 well plates, we measured the OD<sub>600</sub> to normalize our data in the end (assuming a direct correlation between bacterial density and secreted protein). Using the harvested supernatants, we applied a microplate reader based starch hydrolysis assay <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/16500607">[8]</a> and normalized the generated data with the OD<sub>600</sub> values to identify the most potent combinations of SPs and <i>B. subtilis’</i> α-Amylase of each SPM subset (Figure 6).</p> | ||
<p>Finally, we picked a range of promising colonies and amplified the SP containing region via standard PCR using the primers TM4487 and iG17P058. The resulting fragments were sequenced, thus we could identify the most potent SPs for α-Amylase (Figure 7).</p> | <p>Finally, we picked a range of promising colonies and amplified the SP containing region via standard PCR using the primers TM4487 and iG17P058. The resulting fragments were sequenced, thus we could identify the most potent SPs for α-Amylase (Figure 7).</p> | ||
− | <p>We were very much excited to identify several SP which lead to a almost 1.5 fold higher amylase activity when compared to the wilde type! Interestingly we also identified the <i>amyE</i> SP as more potent than the wild type. We explain this, by the way we cloned our construct: due to the RFC25 we by default added two amino acids (AA) (from the scar site derived from the fusion of NgoMIV and AgeI) between the SP and <i>amyE</i>. Apparently, by having this two AA linker, the activity of Amylase could be enhanced. | + | <p>We were very much excited to identify several SP which lead to a almost 1.5 fold higher amylase activity when compared to the wilde type! Interestingly we also identified the <i>amyE</i> SP as more potent than the wild type. We explain this, by the way we cloned our construct: due to the RFC25 we by default added two amino acids (AA) (from the scar site derived from the fusion of NgoMIV and AgeI) between the SP and <i>amyE</i>. Apparently, by having this two AA linker, the activity of Amylase could be enhanced.</p> |
We also identified SP which lead to less Amylase secretion. Overall, we were able to demonstrate a fully functional high-throughput approach to identify most potent partners between Sec dependant SP and a POI. | We also identified SP which lead to less Amylase secretion. Overall, we were able to demonstrate a fully functional high-throughput approach to identify most potent partners between Sec dependant SP and a POI. | ||
− | <p>We also went one step further and proved the applicability of the Signal Peptide Toolbox by evaluating two more proteins: sfGFP and mCherry, according to the procedure described above. | + | <p>We also went one step further and proved the applicability of the Signal Peptide Toolbox by evaluating two more proteins: sfGFP and mCherry, according to the procedure described above.</p> |
<p>The detailed SOP protocols for working with the Evaluation Vector and the Signal Peptide Toolbox can be found down below. The protocol selection explains the use of the <a href="https://2017.igem.org/Team:TU_Dresden/Composite_Part">Evaluation Vector</a>, the Signal Peptide-Evaluation Vector and the high throughput screening procedure for <i>B. subtilis</i>.</p> | <p>The detailed SOP protocols for working with the Evaluation Vector and the Signal Peptide Toolbox can be found down below. The protocol selection explains the use of the <a href="https://2017.igem.org/Team:TU_Dresden/Composite_Part">Evaluation Vector</a>, the Signal Peptide-Evaluation Vector and the high throughput screening procedure for <i>B. subtilis</i>.</p> |
Revision as of 15:11, 31 October 2017